abstract |
PROBLEM TO BE SOLVED: To provide a pharmaceutical composition, a treatment method and a method for identifying a candidate therapeutic agent for administration to a patient, for example, a patient having heart failure. The pharmaceutical composition comprises one or more BCL2-associated athanogene 3 (BAG3) molecules, or an agent that regulates the expression of BAG3. [Selection diagram] Figure 1 |